184 related articles for article (PubMed ID: 8781382)
1. Cigarette smoking and p53 mutations in lung cancer and bladder cancer.
Husgafvel-Pursiainen K; Kannio A
Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):553-6. PubMed ID: 8781382
[TBL] [Abstract][Full Text] [Related]
2. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
3. p53 and K-ras mutations in lung cancers from former and never-smoking women.
Vähäkangas KH; Bennett WP; Castrén K; Welsh JA; Khan MA; Blömeke B; Alavanja MC; Harris CC
Cancer Res; 2001 Jun; 61(11):4350-6. PubMed ID: 11389059
[TBL] [Abstract][Full Text] [Related]
4. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
[TBL] [Abstract][Full Text] [Related]
6. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K
Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962
[TBL] [Abstract][Full Text] [Related]
7. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
Hernandez-Boussard TM; Hainaut P
Environ Health Perspect; 1998 Jul; 106(7):385-91. PubMed ID: 9637795
[TBL] [Abstract][Full Text] [Related]
8. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer.
Habuchi T; Takahashi R; Yamada H; Ogawa O; Kakehi Y; Ogura K; Hamazaki S; Toguchida J; Ishizaki K; Fujita J
Cancer Res; 1993 Aug; 53(16):3795-9. PubMed ID: 8339293
[TBL] [Abstract][Full Text] [Related]
9. Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.
Hainaut P; Pfeifer GP
Carcinogenesis; 2001 Mar; 22(3):367-74. PubMed ID: 11238174
[TBL] [Abstract][Full Text] [Related]
10. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer.
Conway K; Edmiston SN; Cui L; Drouin SS; Pang J; He M; Tse CK; Geradts J; Dressler L; Liu ET; Millikan R; Newman B
Cancer Res; 2002 Apr; 62(7):1987-95. PubMed ID: 11929815
[TBL] [Abstract][Full Text] [Related]
12. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos.
Kannio A; Ridanpää M; Koskinen H; Partanen T; Anttila S; Collan Y; Hietanen E; Vainio H; Husgafvel-Pursiainen K
Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):33-9. PubMed ID: 8770464
[TBL] [Abstract][Full Text] [Related]
13. Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: similarities with the p53 mutation spectrum in smoking-associated lung cancers.
Yoon JH; Smith LE; Feng Z; Tang M; Lee CS; Pfeifer GP
Cancer Res; 2001 Oct; 61(19):7110-7. PubMed ID: 11585742
[TBL] [Abstract][Full Text] [Related]
14. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers.
Pfeifer GP; Denissenko MF; Olivier M; Tretyakova N; Hecht SS; Hainaut P
Oncogene; 2002 Oct; 21(48):7435-51. PubMed ID: 12379884
[TBL] [Abstract][Full Text] [Related]
15. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
[TBL] [Abstract][Full Text] [Related]
16. P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.
LaRue H; Allard P; Simoneau M; Normand C; Pfister C; Moore L; Meyer F; Têtu B; Fradet Y
Carcinogenesis; 2000 Jan; 21(1):101-6. PubMed ID: 10607740
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
[TBL] [Abstract][Full Text] [Related]
18. Human lung cancer and p53: the interplay between mutagenesis and selection.
Rodin SN; Rodin AS
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12244-9. PubMed ID: 11035769
[TBL] [Abstract][Full Text] [Related]
19. p53 mutations in non-small-cell lung cancers occurring in individuals without a past history of active smoking.
Takagi Y; Osada H; Kuroishi T; Mitsudomi T; Kondo M; Niimi T; Saji S; Gazdar AF; Takahashi T; Minna JD; Takahashi T
Br J Cancer; 1998 May; 77(10):1568-72. PubMed ID: 9635830
[TBL] [Abstract][Full Text] [Related]
20. Tobacco and cancer: epidemiology and the laboratory.
Vineis P; Caporaso N
Environ Health Perspect; 1995 Feb; 103(2):156-60. PubMed ID: 7737063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
